by McKesson Ventures | Apr 25, 2023 | Press Releases
Clinical Ink, a global life science technology company, now offers continuous glucose monitoring (CGM) within its integrated digital biomarker solution. The new modules enable remote collection, central storage, and analysis of sensor data from commercially available...
by McKesson Ventures | Apr 25, 2023 | Press Releases
Real-world evidence (RWE) technology and analytics company Aetion has announced the culmination of the RCT-DUPLICATE demonstration project, with complete findings published in The Journal of the American Medical Association (JAMA). This three-year initiative tested...
by McKesson Ventures | Apr 20, 2023 | Portfolio News
In a recent episode of the PharmaPhorum podcast, Evidation co-CEO and Executive Chair of the Board Deborah Kilpatrick discussed healthcare data collection in 2023 and how it intersects with stakeholders across the ecosystem, from tech and pharma companies to research...
by McKesson Ventures | Apr 20, 2023 | Press Releases
Replica Analytics, an Aetion company, has released Replica Synthesis 3.0, its privacy- and utility-preserving synthetic data generation software that has been updated with an enhanced user experience. This makes it easier for analysts to train generative models and...
by McKesson Ventures | Apr 14, 2023 | Press Releases
Bioinformatics company M2GEN has announced that it is rebranding, changing its name to Aster Insights. As the nexus between patients, researchers, and the life sciences industry, the company’s unique clinical and molecular dataset has enabled new insights for...
